Patent details

EP2527360 Title: Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders

Basic Information

Publication number:
EP2527360
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP121629034
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
French Title of Invention:
Agonistes de guanylase cyclase utiles pour le traitement de troubles gastro-intestinaux, d'inflammation, de cancer et d'autres troubles
German Title of Invention:
Für die Behandlung von gastrointestinalen Erkrankungen, Entzündungen, Krebs und anderen Erkrankungen geeignete Agonisten von Guanylatcyclase
SPC Number:

Dates

Filing date:
04/06/2008
Grant date:
28/10/2015
EP Publication Date:
28/10/2015
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
28/11/2012
EP B1 Publication Date:
28/10/2015
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
04/06/2016
Expiration date:
04/06/2028
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
04/06/2008
 
 

Name:
Synergy Pharmaceuticals Inc.
Address:
420 Lexington Avenue Suite 1609, New York, NY 10170, United States (US)

Inventor

1

Name:
Jacob Gary S.
Address:
United States (US)

2

Name:
Shailubhai Kunwar
Address:
United States (US)

Priority

Priority Number:
933194 P
Priority Date:
04/06/2007
Priority Country:
United States (US)

Classification

Main IPC Class:
C07K 7/08;

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages